Profile picture

Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York City (United States of America)
Membership: FESC Member
Follow
Biography
Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, is the Director of the Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine (with Tenure) at the Icahn School of Medicine at Mount Sinai in New York City. After graduating as valedictorian from Boston Latin School, Dr. Bhatt obtained his science degree as a National Merit Scholar at MIT, his MD from Cornell, an MPH from Harvard, and an Executive MBA from Oxford. He trained in internal medicine at the University of Pennsylvania and in cardiology at Cleveland Clinic. He completed fellowships in interventional cardiology and cerebral and peripheral vascular intervention and served as Chief Interventional Fellow at Cleveland Clinic.
Logo ESC

Contributor content

Ask the Trialists - NEO-MINDSET
Session
Ask the Trialists - NEO-MINDSET
31 August 2025
Getting ahead of the curve with early and intensive lipid-lowering strategies for acute coronary syndrome prevention: an interactive case-based challenge
Session
Getting ahead of the curve with early and intensive lipid-lowering strategies for acute coronary syndrome prevention: an interactive case-based challenge
30 August 2025
For high-risk patients it's 15 minutes to midnight on the acute coronary syndrome (ACS) clock: can we stop it?
Session
For high-risk patients it's 15 minutes to midnight on the acute coronary syndrome (ACS) clock: can we stop it?
31 August 2024
HOT LINE 4
Session
HOT LINE 4
27 August 2023
Improving cardiorenal outcomes in type 2 diabetes
Session
Improving cardiorenal outcomes in type 2 diabetes
25 August 2023
Great Debate: antithrombotic therapeutic dilemmas in PAD – dual antiplatelet or dual-pathway antithrombotic therapy?
Session
Great Debate: antithrombotic therapeutic dilemmas in PAD – dual antiplatelet or dual-pathway antithrombotic therapy?
29 August 2021
Controversies in Antiplatelet Treatment: Is Short-Term Dual Antiplatelet Therapy Safe and Effective after PCI?
Session
Controversies in Antiplatelet Treatment: Is Short-Term Dual Antiplatelet Therapy Safe and Effective after PCI?
31 August 2020
Residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice
Session
Residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice
3 September 2019
Cardiovascular drugs in acute coronary syndromes: when to start and when to stop
Session
Cardiovascular drugs in acute coronary syndromes: when to start and when to stop
2 September 2019
Reducing residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice
Session
Reducing residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice
2 September 2019

ESC 365 is supported by